Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
Jane C. Weeks, Paul J. Catalano, Angel M. Cronin, Matthew Finkelman, Jennifer W. Mack, Nancy Lynn Keating, Deborah Schrag
New England Journal of Medicine · 2012 · 1,176 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Weeks, J. C., Catalano, P. J., Cronin, A. M., Finkelman, M., Mack, J. W., Keating, N. L., & Schrag, D. (2012). Patients’ expectations about effects of chemotherapy for advanced cancer. New England Journal of Medicine, 367(17), 1616–1625. https://doi.org/10.1056/nejmoa1204410
In text: (Weeks et al., 2012)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. METHODS: We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. RESULTS: Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. CONCLUSIONS: Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.).
Related papers
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology1993
- TARGET ARTICLE: "Posttraumatic Growth: Conceptual Foundations and Empirical Evidence"2004
- The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma1996
- Optimism, coping, and health: Assessment and implications of generalized outcome expectancies.1985
- The Fatigue Severity Scale1989
Metadata from OpenAlex (CC0). Citations are generated from the published record.